Search results for "Degenerative disease"

showing 10 items of 250 documents

Drug development for neurodegenerative diseases

2021

Drug DevelopmentDrug developmentbusiness.industryClinical BiochemistryHumansMedicineNeurodegenerative DiseasesbusinessBioinformaticsMolecular BiologyBiochemistryBiological Chemistry
researchProduct

Phasor-FLIM analysis of Thioflavin T self-quenching in Concanavalin amyloid fibrils

2020

The formation of amyloid structures has traditionally been related to human neurodegenerative pathologies and, in recent years, the interest in these highly stable nanostructures was extended to biomaterial sciences. A common method to monitor amyloid growth is the analysis of Thioflavin T fluorescence. The use of this highly selective dye, diffused worldwide, allows mechanistic studies of supramolecular assemblies also giving back important insight on the structure of these aggregates. Here we present experimental evidence of self-quenching effect of Thioflavin T in presence of amyloid fibrils. A significant reduction of fluorescence lifetime of this dye which is not related to the propert…

Fluorescence-lifetime imaging microscopyAmyloidFLIMHistologyAmyloid02 engineering and technologyProtein aggregationprotein aggregation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineself-quenchingmental disordersamyloid fibrilConcanavalin Afluorescence lifetimeHumansBenzothiazolesInstrumentationFluorescent DyesInclusion BodiesQuenching (fluorescence)biologyStaining and LabelingChemistryOptical ImagingPhasorNeurodegenerative Diseases030206 dentistry021001 nanoscience & nanotechnologyFluorescenceSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Medical Laboratory TechnologyMicroscopy FluorescenceConcanavalin APhasorbiology.proteinBiophysicsThioflavin TThioflavinamyloid fibrils Concanavalin A FLIM fluorescence lifetime Phasor protein aggregation self-quenching Thioflavin TAnatomy0210 nano-technology
researchProduct

Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series

2013

Objectives: To determine the genetic distribution and the phenotypic correlation of an extensive series of patients with Charcot-Marie-Tooth disease in a geographically well-defined Mediterranean area. Methods: A thorough genetic screening, including most of the known genes involved in this disease, was performed and analyzed in this longitudinal descriptive study. Clinical data were analyzed and compared among the genetic subgroups. Results: Molecular diagnosis was accomplished in 365 of 438 patients (83.3%), with a higher success rate in demyelinating forms of the disease. The CMT1A duplication (PMP22 gene) was the most frequent genetic diagnosis (50.4%), followed by mutations in the GJB1…

Foot DeformitiesMalecongenital hereditary and neonatal diseases and abnormalitiesPathologymedicine.medical_specialtyDNA Mutational AnalysisNerve Tissue ProteinsDiseaseArticleConnexinsCentral nervous system diseaseDegenerative diseasestomatognathic systemCharcot-Marie-Tooth DiseaseGene duplicationHumansMedicineLongitudinal StudiesMuscle StrengthGeneRetrospective StudiesGeneticsSeries (stratigraphy)business.industryRetrospective cohort studymedicine.diseasePhenotypeMuscular Atrophystomatognathic diseasesSpainMutationSensation DisordersFemaleNeurology (clinical)businessMyelin ProteinsNeurology
researchProduct

ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated…

2022

Abstract Background Amyotrophic lateral sclerosis (ALS) is a multifactorial neurodegenerative disease characterised by the loss of upper and lower motor neurons. Increasing evidence indicates that neuroinflammation mediated by microglia contributes to ALS pathogenesis. This microglial activation is evident in post-mortem brain tissues and neuroimaging data from patients with ALS. However, the role of microglia in the pathogenesis and progression of amyotrophic lateral sclerosis remains unclear, partly due to the lack of a model system that is able to faithfully recapitulate the clinical pathology of ALS. To address this shortcoming, we describe an approach that generates monocyte-derived mi…

General NeuroscienceAmyotrophic Lateral SclerosisImmunologyNeurodegenerative DiseasesMonocytesInflammasomeDNA-Binding ProteinsCellular and Molecular NeurosciencePhagocytosisNeurologyDisease ProgressionHumansSettore MED/26 - NeurologiaMicrogliaTDP-43 inclusionsAmyotrophic lateral sclerosiDNA DamageJournal of Neuroinflammation
researchProduct

D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice.

2014

Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) have been discovered in several cancer types and cause the neurometabolic syndrome D2-hydroxyglutaric aciduria (D2HGA). The mutant enzymes exhibit neomorphic activity resulting in production of D2-hydroxyglutaric acid (D-2HG). To study the pathophysiological consequences of the accumulation of D-2HG, we generated transgenic mice with conditionally activated IDH2R140Q and IDH2R172K alleles. Global induction of mutant IDH2 expression in adults resulted in dilated cardiomyopathy, white matter abnormalities throughout the central nervous system (CNS), and muscular dystrophy. Embryonic activation of mutant IDH2 resulted in more pronounced ph…

Genetically modified mouseTransgeneMutantCardiomyopathyMice NudeBiologyIDH2Cell LineGlutarateschemistry.chemical_compoundMiceGeneticsmedicineAnimalsHumansMuscular dystrophyMice Inbred BALB CGlycogenGene Expression ProfilingGene Expression Regulation DevelopmentalHeartNeurodegenerative Diseasesmedicine.diseaseMolecular biologyIsocitrate DehydrogenaseIsocitrate dehydrogenasechemistryMutationCardiomyopathiesDevelopmental BiologyResearch PaperGenesdevelopment
researchProduct

Factors influencing psychological well-being in patients with Parkinson's disease.

2017

Background Both motor and non-motor symptoms could contribute to significant deterioration of psychological well-being in patients with Parkinson's disease (PD). However, its assessment has been only indirectly evaluated using tools based on health-related quality of life (HRQoL), such as the PDQ-39 scale. Objectives To evaluate psychological well-being in PD using a specific tool of assessment, the Psychological Well-being Scale (PWS), and its clinical correlates. Methods This article reports data of patients' perception of health state, as measured by means of the PWS, from an epidemiological, cross-sectional study conducted in Italian PD patients (FORTE Study). We tested possible relatio…

Genetics and Molecular Biology (all)MaleParkinson's diseaseEmotionsPoison controlSocial Scienceslcsh:MedicinePathology and Laboratory MedicineBiochemistrySeverity of Illness IndexAged; Depression; Fatigue; Female; Humans; Italy; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)0302 clinical medicineMathematical and Statistical TechniquesQuality of lifeSurveys and QuestionnairesMedicine and Health SciencesMedicinePsychologySurveys and Questionnaire030212 general & internal medicinelcsh:ScienceDepression (differential diagnoses)FatigueMultidisciplinaryMovement DisordersDepressionNeurodegenerative DiseasesParkinson DiseaseMiddle AgedPsychiatric Status Rating ScalehumanitiesNeurologyItalyPhysical SciencesFemaleStatistics (Mathematics)Clinical psychologyResearch ArticleHumanResearch and Analysis Methods03 medical and health sciencesSigns and SymptomsDiagnostic MedicineSeverity of illnessInjury preventionMental Health and PsychiatryHumansStatistical MethodsAgedPsychiatric Status Rating Scalesparkinson's disease quality of lifeAnalysis of VarianceBiochemistry Genetics and Molecular Biology (all)business.industryMood Disorderslcsh:RBeck Depression InventoryBiology and Life Sciencesmedicine.diseaseHealth CareAgricultural and Biological Sciences (all)Psychological well-beingAged; Depression; Fatigue; Female; Humans; Italy; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Surveys and QuestionnairesQuality of Lifelcsh:QbusinessSleep Disorders030217 neurology & neurosurgeryMathematicsPLoS ONE
researchProduct

Friedreich Ataxia: An Update on Animal Models, Frataxin Function and Therapies

2009

Friedreich ataxia (FRDA) is an autosomal recessive progressively debilitating degenerative disease that principally affects the nervous system and the heart. Although FRDA is considered a rare disease, is the most common inherited ataxia. It is caused by loss-of-function mutations in the FXN gene, mainly an expanded GAA triplet repeat in the intron 1. The genetic defect results in the reduction of frataxin levels, a protein targeted to the mitochondria. Frataxin deficiency leads to mitochondrial dysfunction, oxidative damage and iron accumulation. Studies of the yeast and animal models of the disease have led to propose several different roles for frataxin. Animal models have also been impo…

GeneticsAtaxiabiologyGenetic enhancementDiseaseMitochondrionmedicine.diseaseBioinformaticsPathogenesisDegenerative diseaseFrataxinbiology.proteinmedicinemedicine.symptomGene
researchProduct

Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Stud…

2016

Medical progress and the lifestyle modification have prolonged life expectancy, despite the development of chronic diseases. Support and care for older subjects are often provided by a network of informal caregivers composed of family, friends and neighbors, who are essential in helping older persons to continue living at home. It has been shown that the extent and diversity of informal tasks may jeopardize the physical, mental and social wellbeing of caregivers. The aim of the Informal Carers of Elderly cohort is to define, through a longitudinal study, profiles of caregivers of older patients with a diagnosis of one of the following diseases: cancer (breast, prostate, colorectal), neurode…

GerontologyMaleLongitudinal studyAgingComparative Effectiveness ResearchdemographyTime Factors[SDV]Life Sciences [q-bio]Health StatusHealth-related quality of lifeSocial WorkersMedicine (miscellaneous)DiseaseAnxietylaw.invention[SHS]Humanities and Social SciencesStudy Protocol0302 clinical medicineElderlyRandomized controlled trialCost of IllnesslawNeoplasmsHealth careAdaptation PsychologicalMedicinePharmacology (medical)030212 general & internal medicineLongitudinal StudiesProspective StudiesComputingMilieux_MISCELLANEOUSQualitative ResearchCancerCost-utility[SHS.DEMO] Humanities and Social Sciences/DemographyDepressionAge FactorsNeurodegenerative DiseasesMiddle Aged3. Good healthInformal caregiversCaregiversLongitudinal cohort studyCardiovascular DiseasesResearch DesignCohortFemaleFranceIndependent Living[SHS.DEMO]Humanities and Social Sciences/DemographyChronic disease03 medical and health sciencesSocial supportIntervention (counseling)HumansRandomized studyAgedbusiness.industrySocial SupportLife expectancyQuality of Lifebusiness[ SHS.DEMO ] Humanities and Social Sciences/Demography030217 neurology & neurosurgeryTrials
researchProduct

Neuroprotective potential of Ginkgo biloba in retinal diseases

2019

AbstractLike other tissues of the central nervous system, the retina is susceptible to damage by oxidative processes that result in several neurodegenerative disease such as age-related macular degeneration, diabetic retinopathy, glaucoma, ischaemic retinal disease, retinal disease produced by light oxidation, and detached retina, among other diseases. The use of antioxidant substances is a solution to some health problems caused by oxidative stress, because they regulate redox homeostasis and reduce oxidative stress. This is important for neurodegeneration linked to oxidation processes. In line with this, Ginkgo biloba is a medicinal plant with excellent antioxidant properties whose effect…

Ginkgo biloba - Uso terapéutico.Pharmaceutical SciencePharmacologymedicine.disease_cause01 natural sciencesNeuroprotectionAnalytical Chemistrychemistry.chemical_compoundRetinal DiseasesGinkgo biloba - Therapeutic use.Drug DiscoveryAnimalsHumansMedicinePharmacologyRetinabiologyPlant Extracts010405 organic chemistrybusiness.industryGinkgo bilobaRetina - Diseases - Treatment.System nervous - Degeneration - Treatment.Organic ChemistryNeurodegenerationGinkgo bilobaNeurodegenerative DiseasesRetinalDiabetic retinopathyMacular degenerationmedicine.diseasebiology.organism_classificationEye - Diseases - Treatment.0104 chemical sciencesSistema nervioso - Degeneración - Tratamiento.010404 medicinal & biomolecular chemistryNeuroprotective Agentsmedicine.anatomical_structureComplementary and alternative medicinechemistryOjos - Enfermedades - Tratamiento.Molecular MedicinebusinessOxidative stressPhytotherapyRetina - Enfermedades - Tratamiento.
researchProduct

Health-Related Quality of Life in Old Age: How to Define it, How to Study?

1995

Quality of life, in the words of Alvan R. Feinstein is something like intelligence. “Everyone knows it exists and thinks they can identify it in various ways, but we may not be able to evoke universal agreement on what it is” (Feinstein, 1987, p. 639). This is also true of quality of life when we consider it from a health point of view. The concept itself seems to be perfectly useful, but at the same time there is something very confusing and even irritating about it. What are we talking about when we talk about health-related quality of life? Do we really need this concept if we think of all the countless number of terms and concepts that refer to different dimensions of health-related phe…

Health related quality of lifeChronic degenerative diseaseQuality of life (healthcare)Point (typography)PsychologySocial psychology
researchProduct